Effectiveness of Manual Acupuncture and Standard Therapy Compared to Standard Therapy in Gynecological Cancer Pain
NCT ID: NCT06070363
Last Updated: 2024-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2023-08-29
2023-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients
NCT06769061
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
NCT00070967
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer
NCT03505671
Acupuncture and Integrative Care in Gynecological Surgery
NCT03560388
Usefulness of Acupuncture in Cancer Pain and Quality of Life
NCT00401063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patient will attempt 3-day manual acupuncture therapy with seven days follow up Patient will receive acupuncture therapy daily for 3 days, for 15 minute each day.
The research design in this study was a single-blinded randomized control clinical trial. With outcome measures for
With Subject criteria:
Inclusion Criteria
1. The patient is diagnosed with gynecological cancer
2. Women over 18 years to 65 years
3. Subjects experiencing cancer pain, with VAS ≥4, namely pain caused by:
* tumors,
* before or during a therapeutic process (radiation therapy, chemotherapy, or post-surgery)
* side effect or the result of toxicity of cancer treatment
* Supportive therapy (palliative therapy, painkillers, antidepressants)
4. Willing to participate in this study and sign an informed consent Exclusion Criteria
1\) The patient has a medical emergency / hemodynamically unstable 2) Patients with contraindications for manual acupuncture procedures such as wounds and infections at the point where the puncture will be performed, patients allergic to stainless steel62 3) Uncooperative patients (patients with negative and aggressive affect, who do not allow acupuncture therapy) 4) There is a tumor in the area that will be stabbed and stimulated in the pregnant woman's abdomen, close to the heart, or around the carotid sinus, lymphedema, needle insertion into the prosthesis 5) Patients with heart rhythm disorders 6) The patient uses a pacemaker 7) Patients with disorders of the auricle such as eczema, external otitis, and psoriasis 8) Patients with blood clotting disorders, with platelets \<50,000, and in neutropenic conditions with neutrophils \<1000
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The Patient are cancer patient that experience cancer pain that only receive analgetic drug treatment according to WHO Stepledder of Pain
No interventions assigned to this group
Manual acupuncture and standard Therapy
The Patient are cancer patient that experience cancer paint that receive analgetic drug treatement according WHO stepledder of pain and receive manual acupuncture
Manual Acupuncture
Acupuncture Needle Insertion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual Acupuncture
Acupuncture Needle Insertion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gynecocal cancer with pain ≥ 4 acording Visual Analog scale and receive analgetic medicine
* The pain cause by
1. direct from cancer
2. Treatment proces surgery, radiotherapy, chemotherapy, paliatif treatment, supportive treatment
3. Adverse reaction form treatment and intoxication
Exclusion Criteria
* patient with uncooperative behavior because ith serious psychological disorders, no currently undergoing psychiatric treatment, aggressive behavior, that not allowed for acupuncture.
* Patients with blood clotting disorders, with platelets \<50.000 and in neutropenic condition with \<1000 neutrophils.
The patient has an allergy to stainless steel acupuncture needles. Wounds at the acupuncture point puncture sites, skin infections in the ears. On patients with eczema on the ears, external otitis or psoriasis.
There is a tumor in the area that will be stabbed and stimulated in the stomach pregnant women, close to the heart, or in the area of the carotid sinus lymphedema, insertion into the prosthesis.
Patients with heart rhythm disorders. The patient uses a pace maker.
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Suryamin Suryamin
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suryamin Suryamin
Role: STUDY_DIRECTOR
Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fatmawati Hospital
Jakarta, Dki Jakarta, Indonesia
Persahabatan Hospital
Jakarta, Dki Jakarta, Indonesia
Suryamin Hung
Jakarta, DKI Jakarta, Indonesia
Cipto Mangunkusumo Hospital
Jakarta Pusat, Dki Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-06-1047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.